论文部分内容阅读
慢性非传染性疾病(简称慢病)主要包括心血管疾病、癌症、糖尿病以及慢性呼吸系统疾病。在世界范围内,慢病已成为死亡和残疾的重要原因,全球每年有3500万名以上的患者死于慢性病,数十亿患者的生活质量受到影响。这些疾病也是造成中国人死亡的主要原因,占全年死亡人数比例的85%。根据各国经验,这些疾病中的许多病种是可以预防的,并且是可以治疗的。改善创新药物的可及性,特别是那些能够改善慢病治疗的药物,将给中国的患者带来广泛的临床和经济获益。
Chronic non-communicable diseases (referred to as chronic diseases) mainly include cardiovascular diseases, cancer, diabetes and chronic respiratory diseases. Chronic disease has become an important cause of death and disability worldwide, affecting more than 35 million people worldwide each year from chronic diseases and affecting the quality of life of billions of patients. These diseases are also the major causes of death among Chinese people, accounting for 85% of the death toll in the whole year. According to national experience, many of these diseases are preventable and treatable. Improving access to innovative medicines, especially those that improve the treatment of chronic diseases, will bring a wide range of clinical and economic benefits to patients in China.